Drug Trial Radar · NCT04720261
Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
58
Actual
Start
Apr 26, 2021
Primary completion
May 16, 2023
Study completion May 16, 2023
Sponsor
- Lead sponsor
- University Hospital, RouenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to evaluate the efficacy of a personalized caplacizumab regimen based on ADAMTS13 activity monitoring in adult acquired thrombotic thrombocytopenic purpura (aTTP): This study is a phase II, prospective, multicenter non-inferiority single-arm study.
Conditions
- Thrombotic Thrombocytopenic Purpura, Acquired
Interventions
CaplacizumabDrug
Analyse of ADAMTS13 activity in patients with aTTP treated with Caplacizumab in order to help adapting the treatment with caplacizumab in TTP patients
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the feasibility of a personalized caplacizumab regimen in aTTP based on ADAMTS13 activity monitoring assessed by a composite criteria including mortality, refractoriness and/or exacerbation at 30 days post-PE treatmentTime frame: 30 days post-PE treatment
Locations
24 sites in 2 countries. Site status is shown where the registry gives one.
Chu Amiens
Amiens, France
Chu Angers
Angers, France
Chu Besancon
Besançon, France
Chu Bordeaux
Bordeaux, France
CHU CAEN
Caen, France
Chu Clermont-Ferrand
Clermont-Ferrand, France
Chu Lille
Lille, France
Chu Limoges
Limoges, France
Ch Edouard Herriot
Lyon, France
Ap-Hm Hopital de La Conception
Marseille, France
Chu Montpellier
Montpellier, France
Chu Nancy
Nancy, France
Chu Nantes
Nantes, France
Ah-Hp Hopital Saint Louis
Paris, France
Ap-Hp Hopital de Cochin
Paris, France
Ap-Hp Hopital de Necker
Paris, France
Ap-Hp Hopital de St Antoine
Paris, France
Chu Reims
Reims, France
Chu Rennes
Rennes, France
Chu Rouen
Rouen, France
Reunion Sud
Saint-Paul, France
Chu Tours
Tours, France
Ch Valenciennes
Valenciennes, France
Fort de France
Fort-de-France, Martinique
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.